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Is depressIon overdIagnosed?
Task of primary care is to grade depression Sadness is normal because life can be difficult.
1 2 Sadness in bereavement, for example, is appropriate and healthy-I hope my children will be sad after I've gone. However, sadness is not depression: when it is combined with cognitive, emotional, somative, and behavioural features it becomes the syndrome of depression, with its multifactorial aetiology, so common in primary care. But diagnosis does not mean that treatment or medicalisation is needed. The Diagnostic and Statistical Manual of Mental Disorders (III and IV) divides major depressive disorder into mild, moderate, and severe. The mild form is usually self limiting and responds to cognitive behavioural therapy, support, counselling, St John's wort, reading helpful books, etc. It does not really require a doctor so much as supportive, informed listening people.
At the other end of the spectrum, about a quarter of our depressed patients in east London primary care have severe depression when they present. They are at risk of admission, and about 15% will die from suicide. The syndrome here is so far away from normal function and normal sadness, and medical intervention makes such a difference that it is hard not to conceptualise it as illness. If mild depression is like a cold that we could consider a normal part of life, severe depression is like pneumonia that kills people if we do nothing.
Parker seems to muddle all these forms of depression into one, unhelpfully confusing the issues.
1 If we treat all depression outside hospital as if it were the same we will undertreat some very sick people, and include in medical treatment those we might prefer to find their own help in their own social networks. The task of primary care is to grade depression appropriately and match severity to treatment, and, of course, treatment may include chemicals, talking, support, self help, and more. 
Walking the Black Dog
One of the reasons why people like me who walk the Black Dog become so endlessly frustrated is that those who apparently stand for greater understanding of, and help for, folks like me, seemingly do very little to help the public and media to comprehend the complexity of the depression predicament.
1 2
In addition to working out ways to live with, and recover from, this oft devastating condition, we have constantly to endure those who have never been there, or who have been poorly treated when they have been (with whatever intervention), eroding our experience and neutralising our narratives. A condition that is, to many of us, the most physical we have ever experienced is reduced to the level of an extreme form of appropriate emotionality (which it may admittedly be in some cases) and access to medical treatment is questioned to the point of marginalising our predicament even further. This is effectively the equivalent of saying that people with a diagnosis of diabetes are just a little bit "oversugary" and making them feel bad about taking insulin.
It's not the case (in the United Kingdom) that everyone is being put on drugs. That is the type of catastrophising overgeneralisation that those of us who have had cognitive behavioural therapy are encouraged to dump. The improving access to psychological therapies programme is even now developing collaborative effort to enable stepped care thinking and processes to be applied to those with depression so that at least we can manage better the twin whirlpools of overmedicalisation of appropriate emotionality and the underdiagnosis of a potentially fatal illness.
Christopher L Manning chief executive officer, Primhe, twickenham tW11 9Hg chris.manning@primhe.org Competing interests: ClM chooses to take an SSRi to deal with his own experience of depression as a relapsing condition in spite of all the other interventions on offer. the charities for which he has worked (Depression alliance) and works (Primhe) actively seek (and have to seek) essential funding from various pharmaceutical companies and complementary therapy and psychological intervention providers to enable their work. 
Global perspectives
The debate on whether depression is overdiagnosed should take global and epidemiological perspectives into account. Recent transnational epidemiological surveys have not confirmed that medicalisation of sadness is a general phenomenon in the community. 3 Rather, a substantial proportion of individuals with depression, even of severe degree, do not receive drug or other professional treatments. This is especially so in developing countries (including Beijing and Shanghai in China), where typically less than 10% of people with mood disorders will ever receive any form of professional treatment. 4 The epidemiological meaning of a "case" of depression (such as mild major depressive episode) may have little to do with whether the affected person needs psychiatric evaluation or drug treatment, or both. This is not unlike increasingly lenient public health definitions of physical conditions such as obesity or serum cholesterol concentrations in the general population. In the spirit of early intervention, psychosocial intervention or a change in lifestyle may work better than drugs in alleviating such mild metabolic disturbances.
The real problem for the increasing diagnosis of depression is the poor access to quality psychosocial interventions such as cognitive therapy not only in developing countries but also in much of the developed West. This is despite a strong base of letters evidence showing that such interventions are at least as effective as drugs in treating and preventing depression. In many parts of the world clinical psychology does not exist. 
Carpal tunnel syndrome
Nerve studies are not that useful in diagnosis
The authorship by a neurophysiologist of an article strongly advocating nerve conduction studies for diagnosing carpal tunnel syndrome seems something of an undeclared competing interest. 1 Fortunately, not all Bland's colleagues support his enthusiasm. Clinicians involved in managing this syndrome mostly agree that because of the high rate of false negatives, the test should only be advocated for cases with unusual diagnostic difficulty. Carpal tunnel syndrome usually presents in the early hours of the morning because of extracirculatory shifts in body fluids, so to be truly accurate, nerve conduction tests would also need to be performed at this time of day. Until Bland's department can provide a round the clock service, willynilly requests for nerve studies are more likely to bankrupt the NHS than provide helpful pointers towards firm diagnosis.
As for the article's guidance on treatments, splintage certainly helps with symptoms but does nothing for the underlying condition, and who really wants to go to bed every night wearing a cumbersome splint? As for steroids, as Bland tells us, relapse is common. Am I, therefore, like him also at risk of a conflict of interest in declaring that expert surgery is the only definitive solution? 
All nutritional supplements should be classified as drugs
The study by Canani et al concluded that probiotics should be classified as drugs, and doctors should select preparations for which evidence of efficacy, in a given clinical condition, is supported by solid data.
1 All nutritional supplements that are sold on the basis of their health promoting properties should be classified as drugs, and they should have to undergo the same rigorous process as pharmaceutical drugs to establish their efficacy and safety before they are placed on the market. The global market for probiotics and supplements continues to grow, and a growing number of "nutritionists" and nutritional supplements are trying to cash in. Consumers deserve to have accurate information about the efficacy and potential side effects of these products in the same way that they do for other over the counter drugs. If these substances were classified as drugs, doctors could then prescribe them on the NHS for their specific indication supported by good evidence. There are a few randomised controlled trials of the effectiveness of specific probiotics for certain diagnoses, and for most so called probiotics there is only weak or no evidence of their effectiveness. Classifying such substances as drugs would also make the label "probiotic" meaningful as a substance with proved health benefit and prevent ineffective preparations cashing in by association. medICal eduCatIon researCh reasons to be cheerful
The article by Todres et al raises important questions about the funding challenges of educational research in medicine. 1 They are correct to point out these challenges, but I fear that they continue to add to them by their particular reference to randomised controlled trials (RCTs). This is perhaps a worrying insight into the continuing positivistic "lens" of the profession within a normative paradigm. 2 It is well acknowledged that RCTs are rarely if ever relevant in educational research. 3 It is this continuing and unnecessary conflict of paradigms that not only affects funding but also ethical approval. The National Research Ethics Service has recently provided guidance for conducting research in incapacitated subjects. 2 The guidance has one important omission. The Data Protection Act 1998 provides important safeguards to protect the privacy of individuals, but overly restrictive interpretations of the act by local data protection officers have been a major hindrance to the conduct of legitimate clinical research in critically ill patients. 3 We have been in contact with the Information Commissioner's Office and confirmed that research in incapacitated patients can fulfil the requirements of the Data Protection Act. Our standard research practice is to obtain assent from a patient representative before data processing to ensure that the patient's prior wishes are taken into account. We then obtain consent from the patient, as soon as is practicable, once they regain capacity. We have been advised that this fulfils the requirements of the Data Protection Act ensuring fair processing of information, provided that such processing is essential for the purpose of research, and that such research could not be undertaken with non-identifiable personal data (D Evans, Information Commissioner's Office, personal communications, April UK training framework. These are exciting opportunities to develop academic educators for the future. The positions have a similar funding to the clinician scientist posts within the UK Clinical Research Collaboration and will need further grants in the longer term. This will require major funders of laboratory medicine to review their research profiles.
A second major development has been the formation of the Academy for Medical Educators (AME). The academy's overall aims include developing and sustaining medical education as an academic discipline and supporting academic and professional leadership in medical education. Foundation membership facilities are in place and elections to the first council will start this autumn.
Julian Archer clinical lecturer in medical education, universities of Exeter and Plymouth, C313 Portland Square, Plymouth Pl4 8aa julian.archer@pms.ac.uk Competing interests: Ja is a ukCRC clinical lecturer in medical education at Peninsula College of Medicine and Dentistry and a member of the transitional Council, aME
Other journals, other means
We support the premise that best evidence supports what we do in medical education, as in the best evidence medical education movement.
1 While we agree that Medical Education and Medical Teacher are two leading medical education journals, they mostly focus on undergraduate studies and are not the only publications that accept worthwhile studies from medical and dental education researchers. For instance, we were surprised that the authors, from a department of general practice, did not mention Education for Primary Care, which publishes medical education research with a primary care and postgraduate focus. As researchers concentrating on postgraduate medical and dental education, we also look at papers published in Postgraduate Medical Journal and dental education journals, in addition to education journals, such as the Journal of Qualitative Research and Evaluation. We also present our work at national and international medical education conferences. Again, these were not mentioned.
We agree that more needs to be done to foster research into medical and dental
and August 2007).
We urge the National Research Ethics Service to include advice on this topic on their website after appropriate consultation with the Information Commissioner's Office. 
Idea In aCtIon?
Generic ID card to save jobs
Hitchen's report highlights UK trusts' failure to balance their books because they recruit "too many" staff. 1 However I recently undertook an interesting calculation based on the many hospital identity cards I have accrued since graduating in 2001. Having been fortunate enough to secure a rotation in my chosen specialty after house jobs and accident and emergency experience, I have collected nine such cards to date. If all 39 000 junior doctors in the United Kingdom duplicated my experience, which cannot be uncommon with six monthly job changes, and assuming a price of around £1.00 a card, a total of £351 000 has been spent on the production of multiple ID cards for UK juniors. Associated hardware (at an additional estimated £1000 for every UK NHS hospital trust) has cost a further £200 000, assuming it is a one-off cost.
I look forward to the day a generic card can be taken from job to job, just as my debit card can dispense cash from a variety of banks. If such a card existed in January 2007, 11 more of us could secure run-through posts under Modernising Medical Careers (MMC) in August 2007, bringing the English total number of posts in ophthalmology to 305. 2 Perhaps there are other areas of "professional repetition" where savings could be envisaged. 
